NCT07081360View on ClinicalTrials.gov

Neoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary Cancer

PHASE3RecruitingINTERVENTIONAL
Enrollment

262

Participants

Timeline

Start Date

July 20, 2025

Primary Completion Date

July 20, 2028

Study Completion Date

August 20, 2028

Conditions
Pancreas CancerPeriampullary CancerPeriampullary Carcinoma ResectablePancreatic Cancer ResectableAmpullary CancerPancreas Adenocarcinoma
Interventions
DRUG

Neoadjuvant chemotherapy

Neoadjuvant chemotherapy (mFOLFIRINOX) followed by pancreaticoduodenectomy

PROCEDURE

Upfront Surgery Group

Pancreaticoduodenectomy followed by adjuvant chemotherapy

Trial Locations (1)

61519

RECRUITING

Liver and GIT hospital , Minia University, Minya

All Listed Sponsors
lead

Minia University

OTHER